Mayo Clinic the first health system to offer Cologuard

Exact Sciences has announced that Mayo Clinic will be the first health care system to offer Cologuard, the Madison life sciences firm’s innovative stool-based colorectal cancer screening test. Mayo Clinic, which collaborated with Exact Sciences in developing the test, will make it available to its patients through their primary-care physicians. Cologuard recently became the first test of its kind to win FDA approval.

“Cologuard represents a significant advancement in identifying colorectal cancer at its most treatable stage,” said Vijay Shah, Mayo Clinic’s chair of gastroenterology and hepatology, in a release. “We believe offering this new tool will promote patient and community public health and may move more patients to get screened earlier—a critical step in beating this prevalent and preventable cancer.”